ArticleJHEP reports : innovation in hepatology2025

Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma.

Evangelia E Tsakiridis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.